SYK |
SYK: Tyrosine-protein kinase SYK |
BLNK |
IPI00718885 |
2.622 |
Evidence |
|
BCL2L14 |
BCL2L14, BCLG: Apoptosis facilitator Bcl-2-like 14 protein |
BCL2L12 |
BCL2L12, BPR: Bcl-2-related proline-rich protein |
2.622 |
Evidence |
|
MSC |
MSC, ABF1: Musculin |
TFEC |
TFEC, Tfec, tcag7.74: TFEC isoform |
2.622 |
Evidence |
|
DEDD2 |
DEDD2, FLAME3, PSEC0004: DNA-binding death effector domain-containing protein 2 |
ANK1 |
IPI00297532 |
2.622 |
Evidence |
|
MEFV |
IPI00375378 |
CASP5 |
CASP5, ICH3: Caspase-5 precursor |
2.622 |
Evidence |
|
TCF3 |
IPI00216911 |
TAL1 |
TAL1, SCL, TCL5: T-cell acute lymphocytic leukemia protein 1 |
2.622 |
Evidence |
|
ZNF271 |
IPI00031623 |
ZNF287 |
ZNF287, ZKSCAN13: Zinc finger protein 287 |
2.622 |
Evidence |
|
HLA-DOB |
HLA-DOB: HLA class II histocompatibility antigen, DO beta chain precursor |
HLA-G |
HLA-G, DAQB-346J13.1-002, DASS-366B6.2-002, XXbac-BCX209H21.15-002, XXbac-BPG12I |
2.622 |
Evidence |
|
NALP5 |
NLRP5, MATER, NALP5: NACHT, LRR and PYD domains-containing protein 5 |
NFKB2 |
IPI00477537 |
2.622 |
Evidence |
|
BLNK |
IPI00718885 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
2.622 |
Evidence |
|
HLA-DQA1 |
HLA class II histocompatibility antigen, DQ(W3) alpha chain precursor |
B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
2.622 |
Evidence |
|
HLA-F |
HLA-F, HLA-5.4, HLAF: HLA class I histocompatibility antigen, alpha chain F prec |
NULL |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-38 alpha chain precursor |
2.622 |
Evidence |
|
BMF |
BMF: Bcl-2-modifying factor |
BOK |
BOK: Bcl-2-related ovarian killer protein |
2.622 |
Evidence |
|
BCL2L11 |
BCL2L11, BIM: Bcl-2-like protein 11 |
BCL2L12 |
BCL2L12, BPR: Bcl-2-related proline-rich protein |
2.622 |
Evidence |
|
BHLHB8 |
BHLHB8, MIST1: Class B basic helix-loop-helix protein 8 |
PHTF1 |
PHTF1, PHTF: Putative homeodomain transcription factor 1 |
2.622 |
Evidence |
|
TCF3 |
IPI00216911 |
MXD1 |
MXD1, MAD: MAD protein |
2.622 |
Evidence |
|
LHCGR |
LHCGR, LCGR, LGR2, LHRHR: Lutropin-choriogonadotropic hormone receptor precursor |
CALR |
CALR, CRTC: Calreticulin precursor |
2.622 |
Evidence |
|
BMPR1B |
BMPR1B: Bone morphogenetic protein receptor type IB precursor |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
2.622 |
Evidence |
|
MPDZ |
MPDZ, MUPP1: Multiple PDZ domain protein |
KCNA2 |
KCNA2: Potassium voltage-gated channel subfamily A member 2 |
2.622 |
Evidence |
|
RAB36 |
RAB36: Ras-related protein Rab-36 |
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
2.622 |
Evidence |
|
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
PLAUR |
PLAUR, MO3, UPAR: Urokinase plasminogen activator surface receptor precursor |
2.62 |
Evidence |
|
IKBKE |
IKBKE, IKKE, IKKI, KIAA0151: Inhibitor of nuclear factor kappa-B kinase subunit |
TNFRSF1A |
TNFRSF1A, TNFAR, TNFR1: Tumor necrosis factor receptor superfamily member 1A pre |
2.62 |
Evidence |
|
NPR3 |
IPI00013826 |
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
2.62 |
Evidence |
|
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
CNN3 |
CNN3: Calponin-3 |
2.62 |
Evidence |
|
CGA |
CGA: Glycoprotein hormones alpha chain precursor |
MMRN1 |
MMRN1, ECM, EMILIN4, MMRN: Multimerin-1 precursor |
2.62 |
Evidence |
|